Jose H. Flores‐Arredondo

Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease

Michelle L. O’Donoghue, Robert P. Giugliano, Stephen D. Wiviott et al. · Circulation · 2022 · 380 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE

Prakriti Gaba, Michelle L. O’Donoghue, Jeong‐Gun Park et al. · Circulation · 2023 · 173 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Full Expression of Cardiomyopathy Is Partly Dependent on B‐Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis

Andrea M. Cordero‐Reyes, Keith A. Youker, Alejandro R. Trevino et al. · Journal of the American Heart Association · 2016 · 105 citations · Full text

Life Sciences, Cardiology, Immunology +15

Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · Journal of the American College of Cardiology · 2021 · 102 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression

Keith A. Youker, Christian Assad‒Kottner, Andrea M. Cordero‐Reyes et al. · European Heart Journal · 2013 · 63 citations · Full text

Life Sciences, Cardiology, Immunology +12